Open, Parallel and Randomised Pilot Clinical Trial to Evaluate the Utility of the Therapeutic Monitoring of Plasma Levels of Efavirenz in Hiv-Infected Patients Initiating an Antiretroviral Treatment Regimen With Sustiva.
Phase of Trial: Phase IV
Latest Information Update: 15 Feb 2018
At a glance
- Drugs Efavirenz (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms startTDM-EFV
- 10 Jun 2017 Biomarkers information updated
- 14 Oct 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 Oct 2006 New trial record.